Evolent Health Inc.

NYSE: EVH · Real-Time Price · USD
9.27
0.45 (5.10%)
At close: Aug 15, 2025, 3:45 PM
8.82
0.00%
Pre-market: Aug 15, 2025, 09:03 AM EDT

Evolent Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
444.33M 483.65M 646.54M 621.4M 647.14M 639.65M 556.05M 511.01M 469.14M 427.69M 382.43M 352.58M 319.94M 297.06M 248.36M 222.47M 222.06M 215.07M
Cost of Revenue
343.94M 381.18M 570.83M 540.71M 570.47M 565.05M 454.43M 386.58M 351.94M 310.48M 299.37M 266.62M 249.71M 219.74M 164.48M 163.13M 172.11M 157.83M
Gross Profit
77.24M 102.47M 75.71M 80.69M 76.67M 74.6M 101.63M 124.43M 117.2M 117.22M 83.06M 85.97M 70.23M 77.32M 83.88M 59.34M 49.94M 57.24M
Operating Income
-1.17M -1.62M -18.6M -16.27M 7.79M 5.83M -21.35M -17.94M -21.57M -1.79M -19.58M 12.95M -1.36M 4.17M -12.21M -6.58M -7.67M -15.95M
Interest Income
1.08M 1.27M 830K 794K 1.37M 2.55M 2.52M 1.07M 604K 1.06M 604K 425K 223K 117K 96K 120K 68K 123K
Pretax Income
-20.72M -63.15M -23.92M -23.76M 1.36M -16.71M -48.07M -30.87M -35.29M -88.17M -10.23M -43.39M -4.31M -4.15M 2.6M -12.81M -9.02M -10.58M
Net Income
-51.09M -64.62M -22.8M -23.14M 1.6M -17.28M -33.41M -25.32M -34.32M -19.98M -11.35M 2.12M -4.13M -5.35M -5.65M -13.04M -9.11M -9.81M
Selling & General & Admin
75.21M 78.41M 47.7M 67.06M 67.22M 68.78M 81.43M 96.57M 90.39M 89.73M 82.86M 68.52M 58.95M 58.93M 66.92M 51.29M 42.7M 58.59M
Research & Development
n/a n/a n/a n/a 6.7M 6.3M 6.6M 6.6M 6.8M 6.7M 7.4M 6.4M 3.8M 4.1M 6.5M 6.7M 6.6M 10.1M
Other Expenses
26.35M 25.68M 46.61M 29.9M 25.14M 42.44M 34.95M 39.2M -26K 29.27M 19.78M -43.22M 15.11M 15.11M 22.9M -41K -18K 22.95M
Operating Expenses
101.56M 104.09M 94.31M 96.96M 99.06M 117.52M 122.98M 142.37M 122.52M 119M 102.64M 85.72M 74.07M 74.04M 81.99M 66.15M 57.62M 73.78M
Interest Expense
11.6M 10.38M 6.72M 6.01M 6M 6M 12.24M 14.61M 14.46M 12.89M 6.43M 4.75M 2.15M 2.24M 6.45M 6.37M 6.27M 6.34M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -10.33M n/a n/a n/a n/a -35.03M n/a n/a n/a -34.37M n/a n/a n/a
Cost & Expenses
445.5M 485.27M 665.14M 637.67M 637.69M 653.06M 577.4M 528.95M 474.46M 429.48M 402.01M 352.33M 323.77M 293.78M 246.47M 229.28M 229.73M 231.61M
Income Tax Expense
-825K 1.47M -1.12M -619K -238K 565K -14.66M -5.55M -970K -68.19M 1.12M -45.52M -184K 1.2M -453K 234K 91K 611K
Shares Outstanding (Basic)
115.88M 115.31M 115.03M 114.86M 114.69M 114.14M 113.59M 112.28M 111.28M 107.78M 99.8M 95.29M 90.07M 89.51M 88.33M 85.8M 85.45M 84.67M
Shares Outstanding (Diluted)
115.88M 115.31M 115.03M 114.86M 114.69M 114.14M 113.59M 112.28M 111.28M 107.78M 99.8M 99.31M 90.07M 89.51M 88.33M 85.8M 85.45M 84.67M
EPS (Basic)
-0.44 -0.63 -0.27 -0.27 -0.06 -0.22 -0.36 -0.3 -0.31 -0.19 -0.11 0.02 -0.05 -0.06 -0.06 -0.15 -0.11 -0.12
EPS (Diluted)
-0.44 -0.63 -0.27 -0.27 -0.06 -0.22 -0.36 -0.3 -0.31 -0.19 -0.11 0.02 -0.05 -0.06 -0.06 -0.15 -0.11 -0.12
EBITDA
14.02M -28.7M 13.29M 11.96M 40.44M 18.79M -6.23M 18.48M 14.68M -43.71M 15.98M -19.86M 12.95M 13.2M 24.12M 8.42M 17.43M 14M
EBIT
-9.12M -52.76M -17.2M -17.75M 7.35M 5.83M -35.83M -16.26M -20.84M -75.28M -3.8M -38.64M -2.16M -1.91M 9.05M -6.44M -2.74M -4.24M
Depreciation & Amortization
23.14M 24.06M 30.49M 29.7M 30.98M 29.5M 29.6M 34.74M 35.52M 31.57M 28.07M 17.2M 15.11M 15.11M 15.07M 14.86M 20.17M 18.24M